Skip to content

Dr. Sylvie Van Bylen

Active Private limited companyfounded 2008active for 17 yearsKempenlandstraat 75, 2660 AntwerpKBO/BCE: BE 0808.601.304

Lifetime

17 annual accounts with figures on one time axis
peak €297,026 (2024)
€288,512▼ 2.9%
peak €215,099 (2025)
€215,099▲ 0.9%
peak €1.4m (2025)
€1.4m▲ 11.7%
€56,329▲ 16.6%
Board2 names since 2008
Documentsfilings and deeds
30-07-20261 day before the deadline
2025micro format
Dividend €71,010Debts from €48,320 to €56,329

Key points

from the 2025 annual accounts

Equity

€1.4m ▲ 11.7%

Dr. Sylvie Van Bylen has made a profit in every financial year since 2009.

Turnover

≈ €580,000 estimated

The micro format states no turnover.

Filings

17 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

The 2019 accounts came 56 days late. The other nine of the last ten were filed on time.

Checked score

96
Excellent
Financially stronger than 71% of micro companies without a NACE code
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.1 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: 0.1%▲ +0.1 percentage points vs 06-2026 08-2026: < 0.1%▼ -0.1 percentage points vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026

Financial strength
Strong

100=equity 96.1% of total assets
65+2short-term debt 3.9% · cash 12.0%
87-3return on assets 15.0%

Score breakdown

raises risk
No registered site in the KBO
lowers risk
Size: total assets €1.4m
Equity €1.4m (96.1% of total assets)
Figures for financial year 2025 (filed on 05-08-2026)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 61% on liquidity, 70% on profitability and 69% on growth.

The bankruptcy probability was computed on 08-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 17,811 companies had the same profile as Dr. Sylvie Van Bylen has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

That fits the bankruptcy probability of Dr. Sylvie Van Bylen itself: < 0.1% within 12 months.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,811 companies, not a prediction for Dr. Sylvie Van Bylen. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €130,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 21.97 (22.37 in 2024), above the usual 1.5. Short-term debt is 3.9% and cash 12% of total assets. 3.9% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €1.4m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €1.4m (96.1% of total assets)
NBB · annual accounts
raises risk · No registered site in the KBO
KBO · seat and establishments
lowers risk · Figures for financial year 2025 (filed on 05-08-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
1 day early
2024
22 days early
2023
14 days early
2022
20 days early
2021
17 days early
2020
11 days early
2019
56 days late
← before the deadline after the deadline →
tick = median of all Belgian filings

The company filed its last 7 accounts on average 4 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 14 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
09-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

VB
Director, since 15-12-2008
LC
Director
Board & ownership

Recent changes

Appointment: Lieselotte Coenen (director) General meeting of 30-09-2026 · Gazette deed
Appointment: VAN BYLEN Sylvie (director) Gazette deed
Incorporation published on 02-01-2009 · Gazette deed
All 28 events

Official details

Source: KBO
Status
Active since 22-12-2008Normal situation
Activity
“De uitoefening van de huisartsgeneeskunde door de arts-aandeelhouder-huisarts of door artsen van dezelfde of…” (deed in Dutch)From the articles, 2 activitiesNo NACE code in the KBO yet
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€1.4m▲ 11.8%
Filing
Filed on 30-07-2026, 1 day before the end of the filing period
Financials

Insights on Dr. Sylvie Van Bylen

Dr. Sylvie Van Bylen files the micro format. That format states no turnover. The gross margin rose from €93,511 in 2009 to €288,512 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Sylvie Van Bylen

What is the company number of Dr. Sylvie Van Bylen?
The company number of Dr. Sylvie Van Bylen is 0808.601.304. The VAT number is the same number with BE in front: BE 0808.601.304.
Where is Dr. Sylvie Van Bylen based?
The registered office is at Kempenlandstraat 75, 2660 Antwerp.Company details
What is the legal form of Dr. Sylvie Van Bylen?
Dr. Sylvie Van Bylen is a private limited company (BV).
When was Dr. Sylvie Van Bylen founded?
Dr. Sylvie Van Bylen was founded on 22-12-2008.
Is Dr. Sylvie Van Bylen still active?
Yes, Dr. Sylvie Van Bylen is an active enterprise in the KBO register.
What is the turnover of Dr. Sylvie Van Bylen?
The turnover in financial year 2025 is ≈ €580,000. This figure is estimated from the gross margin of €288,512 and 879 comparable companies of the same size. It probably lies between €400,000 and €840,000. It is a rough estimate.Financials
Is Dr. Sylvie Van Bylen profitable?
In financial year 2025, Dr. Sylvie Van Bylen made a profit of €215,099.
Where can I find the annual accounts of Dr. Sylvie Van Bylen?
Dr. Sylvie Van Bylen filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Sylvie Van Bylen due?
Dr. Sylvie Van Bylen must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.